Comments: NJ A3621 | 2024-2025 | Regular Session
Bill Title: Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced) 2024-02-12 - Introduced, Referred to Assembly Health Committee [A3621 Detail]
Text: Latest bill text (Introduced) [HTML]
Spectrum: Partisan Bill (Democrat 1-0)
Status: (Introduced) 2024-02-12 - Introduced, Referred to Assembly Health Committee [A3621 Detail]
Text: Latest bill text (Introduced) [HTML]
PolitiCorps Conversations
Start PolitiCorps DebateTitle | PolitiCorps | Access | Comments | Views | Last Post |
---|---|---|---|---|---|
There are no visible public or private PolitiCorps discussions concerning the 2024 New Jersey A3621 at this time. |